ROSGQ (Rosetta Genomics) Other Stockholders Equity: $0.00 Mil (As of Jun. 2017)


What is Rosetta Genomics Other Stockholders Equity?

Rosetta Genomics ROSGQ -99.00% Other Stockholders Equity is $0.00 Mil as of Jun. 2017.

Rosetta Genomics's Other Stockholders Equity for the quarter that ended in Jun. 2017 was $0.00 Mil.

Rosetta Genomics's quarterly Other Stockholders Equity declined from Jun. 2016 ($-0.00 Mil) to Dec. 2016 ($-0.00 Mil) but then increased from Dec. 2016 ($-0.00 Mil) to Jun. 2017 ($0.00 Mil).

Rosetta Genomics's annual Other Stockholders Equity increased from Dec. 2014 ($-0.00 Mil) to Dec. 2015 ($0.00 Mil) but then declined from Dec. 2015 ($0.00 Mil) to Dec. 2016 ($-0.00 Mil).

Rosetta Genomics Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Rosetta Genomics's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Rosetta Genomics Other Stockholders Equity Chart

Rosetta Genomics Annual Data
Trend Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16
Other Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.00 -0.00 -0.00 0.00 -0.00

Rosetta Genomics Semi-Annual Data
Dec07 Jun08 Dec08 Jun09 Dec09 Jun10 Dec10 Jun11 Dec11 Jun12 Dec12 Jun13 Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 -0.00 -0.00 0.00

Rosetta Genomics Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of $0.00 Mil mean?
Rosetta Genomics (ROSGQ) has a Other Stockholders Equity of $0.00 Mil as of Jun. 2017. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Rosetta Genomics and its competitors.
Is Rosetta Genomics' Other Stockholders Equity too high?
Rosetta Genomics' current Other Stockholders Equity is $0.00 Mil.
How does Rosetta Genomics' Other Stockholders Equity compare to TEAR and IDTA?
Rosetta Genomics' Other Stockholders Equity of $0.00 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Medical Diagnostics & Research company?
A good Other Stockholders Equity depends on the Medical Diagnostics & Research industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Rosetta Genomics and its competitors. Rosetta Genomics's current Other Stockholders Equity is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rosetta Genomics stock overvalued right now?
Rosetta Genomics (ROSGQ) has a current Other Stockholders Equity of $0.00 Mil. The current Other Stockholders Equity is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For Rosetta Genomics (ROSGQ), the current Other Stockholders Equity is $0.00 Mil as of Jun. 2017. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Rosetta Genomics Business Description

Address 10 Plaut Street, Science Park, Rehovot, ISR, 76706
Rosetta Genomics Ltd is an Israel based genomic diagnostics company operating globally. It is focused on research and development on diagnostics and therapeutics in the field of microRNAs. The firm markets and sells four diagnostic tests based on its microRNA technologies namely, RosettaGX Cancer Origin for the identification of the primary site of metastatic cancer, mi-LUNG, mi-KIDNEY which is a microRNA-based kidney tumor classification test for pathology samples and RosettaGx Reveal which is a microRNA-based assay for the diagnosis of indeterminate thyroid fine-needle aspirate samples. Its revenues include Clinical testing revenues and Licensing revenues, of which Clinical testing revenue is maximum. The group generates its revenues mainly from diagnosing patient tissue.